HCM
TRIB

Highlander Capital Management’s Trinity Biotech TRIB Stock Holding History

Highlander Capital Management’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-400
Closed -$22K – 854
2015
Q3 		$22K Hold
400
– – 0.02% 521
2015
Q2 		$36K Hold
400
– – 0.03% 427
2015
Q1 		$39K Hold
400
– – 0.03% 430
2014
Q4 		$35K Hold
400
– – 0.03% 453
2014
Q3 		$36.5K Hold
400
– – 0.03% 410
2014
Q2 		$46.1K Buy
+400
New +$47.4K 0.04% 367

Other funds holding TRIB

Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return

Highlander Capital Management's TRIB Position: Q4 2015 in Review

Highlander Capital Management sold out of Trinity Biotech (TRIB) in Q4 2015, closing a stake of 400 shares — an estimated $22K sold.

Highlander Capital Management first reported a position in TRIB in Q2 2014 and held it in 6 quarters. The position peaked at $46.1K in Q2 2014. 82 funds tracked by Wall St. Rank hold TRIB as of Q4 2015.

  • Highlander Capital Management reported no remaining Trinity Biotech position as of Q4 2015 after selling out during the quarter.
  • Highlander Capital Management sold 400 Trinity Biotech shares in Q4 2015, an estimated $22K.
  • Highlander Capital Management first reported a position in Trinity Biotech in Q2 2014 and held it in 6 quarters.
  • Highlander Capital Management's Trinity Biotech position peaked at $46.1K in Q2 2014.
  • 82 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2015.

Based on Highlander Capital Management's 13F filing for Q4 2015, filed 10 Feb 2016.